These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 33783322)

  • 1. Understanding the relationship between norovirus diversity and immunity.
    Ford-Siltz LA; Tohma K; Parra GI
    Gut Microbes; 2021; 13(1):1-13. PubMed ID: 33783322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in human norovirus research and implications for candidate vaccines.
    Cates JE; Vinjé J; Parashar U; Hall AJ
    Expert Rev Vaccines; 2020 Jun; 19(6):539-548. PubMed ID: 32500763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noroviruses: epidemiology, immunity and prospects for prevention.
    Pringle K; Lopman B; Vega E; Vinje J; Parashar UD; Hall AJ
    Future Microbiol; 2015; 10(1):53-67. PubMed ID: 25598337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progress on norovirus vaccine research: public health considerations and future directions.
    Mattison CP; Cardemil CV; Hall AJ
    Expert Rev Vaccines; 2018 Sep; 17(9):773-784. PubMed ID: 30092671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The state of norovirus vaccines.
    Debbink K; Lindesmith LC; Baric RS
    Clin Infect Dis; 2014 Jun; 58(12):1746-52. PubMed ID: 24585561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in norovirus biology.
    Karst SM; Wobus CE; Goodfellow IG; Green KY; Virgin HW
    Cell Host Microbe; 2014 Jun; 15(6):668-80. PubMed ID: 24922570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon responses to norovirus infections: current and future perspectives.
    Jahun AS; Goodfellow IG
    J Gen Virol; 2021 Oct; 102(10):. PubMed ID: 34698626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noroviruses-The State of the Art, Nearly Fifty Years after Their Initial Discovery.
    Ludwig-Begall LF; Mauroy A; Thiry E
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-Host Interactions Between Nonsecretors and Human Norovirus.
    Lindesmith LC; Brewer-Jensen PD; Mallory ML; Jensen K; Yount BL; Costantini V; Collins MH; Edwards CE; Sheahan TP; Vinjé J; Baric RS
    Cell Mol Gastroenterol Hepatol; 2020; 10(2):245-267. PubMed ID: 32289501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of immune and viral correlates of norovirus protective immunity through comparative study of intra-cluster norovirus strains.
    Zhu S; Regev D; Watanabe M; Hickman D; Moussatche N; Jesus DM; Kahan SM; Napthine S; Brierley I; Hunter RN; Devabhaktuni D; Jones MK; Karst SM
    PLoS Pathog; 2013; 9(9):e1003592. PubMed ID: 24039576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New insights into the global burden of noroviruses and opportunities for prevention.
    Hall AJ; Glass RI; Parashar UD
    Expert Rev Vaccines; 2016 Aug; 15(8):949-51. PubMed ID: 27142965
    [No Abstract]   [Full Text] [Related]  

  • 12. Primary high-dose murine norovirus 1 infection fails to protect from secondary challenge with homologous virus.
    Liu G; Kahan SM; Jia Y; Karst SM
    J Virol; 2009 Jul; 83(13):6963-8. PubMed ID: 19403675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future.
    Ghosh S; Malik YS; Kobayashi N
    Curr Drug Metab; 2018; 19(3):170-191. PubMed ID: 28901254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-existing immunity to norovirus GII-4 virus-like particles does not impair de novo immune responses to norovirus GII-12 genotype.
    Tamminen K; Huhti L; Vesikari T; Blazevic V
    Viral Immunol; 2013 Apr; 26(2):167-70. PubMed ID: 23438469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population Genomics of GII.4 Noroviruses Reveal Complex Diversification and New Antigenic Sites Involved in the Emergence of Pandemic Strains.
    Tohma K; Lepore CJ; Gao Y; Ford-Siltz LA; Parra GI
    mBio; 2019 Sep; 10(5):. PubMed ID: 31551337
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Within-host evolution results in antigenically distinct GII.4 noroviruses.
    Debbink K; Lindesmith LC; Ferris MT; Swanstrom J; Beltramello M; Corti D; Lanzavecchia A; Baric RS
    J Virol; 2014 Jul; 88(13):7244-55. PubMed ID: 24648459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal P particle vaccine provided partial cross-variant protection against human GII.4 norovirus diarrhea in gnotobiotic pigs.
    Kocher J; Bui T; Giri-Rachman E; Wen K; Li G; Yang X; Liu F; Tan M; Xia M; Zhong W; Jiang X; Yuan L
    J Virol; 2014 Sep; 88(17):9728-43. PubMed ID: 24920797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Norovirus.
    Robilotti E; Deresinski S; Pinsky BA
    Clin Microbiol Rev; 2015 Jan; 28(1):134-64. PubMed ID: 25567225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccine against norovirus.
    Tan M; Jiang X
    Hum Vaccin Immunother; 2014; 10(6):1449-56. PubMed ID: 24718366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric GII.4 norovirus virus-like-particle-based vaccines induce broadly blocking immune responses.
    Debbink K; Lindesmith LC; Donaldson EF; Swanstrom J; Baric RS
    J Virol; 2014 Jul; 88(13):7256-66. PubMed ID: 24741081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.